C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00921752

Acronym

C2 -CORVUS

Enrollment

1500

Registered

2009-06-16

Start date

2009-05-31

Completion date

2009-11-30

Last updated

2009-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Risk

Keywords

Lipid therapy, high CV risk, lipid goal attainment, High cardiovascular risk patients

Brief summary

To demonstrate a higher percent rate of achieved target lipid goals among patients at high cardiovascular risk using more potent lipid-lowering treatment options including high-potency statins and combination therapies.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients at high cardiovascular risk according to Framingham or SCORE rates

Exclusion criteria

* Not eligible for lipid or statin therapy * Intolerance to therapy * Patients at low or intermediate CV risk

Design outcomes

Primary

Measure	Time frame
Percent rate of patients achieving target LDL cholesterol goals	On each of the 3 visits performed during the study
Percent rate of patients achieving 50% or more reduction in LDL-cholesterol	On each of the 3 visits performed during the study

Secondary

Measure	Time frame
Percent rate of patients achieving target secondary (total Ch, triglycerides, HDL Ch) goals	On each of the 3 visits performed during the study
Percent rate of compliance among patients in the study	On each of the 3 visits performed during the study

Countries

Hungary

Outcome results